Source: GWASCAT

Gene Gene Full Name DSI g DPI g pLI Disease Type Score gda EL gda EI gda N. PMIDs N. SNPs gda First Ref. Last Ref.
Entrez Id: 2104
Gene Symbol: ESRRG
ESRRG 		estrogen related receptor gamma 0.621 0.692 7.1E-02
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 387890
Gene Symbol: TMEM233
TMEM233 		transmembrane protein 233 1.000 9.1E-02
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 148534
Gene Symbol: TLCD4
TLCD4 		TLC domain containing 4 0.931 0.038 0.26
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 23194
Gene Symbol: FBXL7
FBXL7 		F-box and leucine rich repeat protein 7 0.769 0.346 0.31
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 1415
Gene Symbol: CRYBB2
CRYBB2 		crystallin beta B2 0.623 0.462 0.39
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 6768
Gene Symbol: ST14
ST14 		suppression of tumorigenicity 14 0.514 0.769 0.56
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 753
Gene Symbol: LDLRAD4
LDLRAD4 		low density lipoprotein receptor class A domain containing 4 0.769 0.231 0.62
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 2113
Gene Symbol: ETS1
ETS1 		ETS proto-oncogene 1, transcription factor 0.444 0.731 0.78
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 79886
Gene Symbol: CAAP1
CAAP1 		caspase activity and apoptosis inhibitor 1 0.861 0.077 0.78
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 3660
Gene Symbol: IRF2
IRF2 		interferon regulatory factor 2 0.575 0.769 0.80
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 864
Gene Symbol: RUNX3
RUNX3 		RUNX family transcription factor 3 0.459 0.731 0.84
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 22871
Gene Symbol: NLGN1
NLGN1 		neuroligin 1 0.705 0.385 0.85
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 105
Gene Symbol: ADARB2
ADARB2 		adenosine deaminase RNA specific B2 (inactive) 0.716 0.308 0.86
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 8091
Gene Symbol: HMGA2
HMGA2 		high mobility group AT-hook 2 0.429 0.808 0.87
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 9580
Gene Symbol: SOX13
SOX13 		SRY-box transcription factor 13 0.743 0.385 0.94
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 604
Gene Symbol: BCL6
BCL6 		BCL6 transcription repressor 0.444 0.808 0.96
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 23236
Gene Symbol: PLCB1
PLCB1 		phospholipase C beta 1 0.595 0.654 0.98
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 9215
Gene Symbol: LARGE1
LARGE1 		LARGE xylosyl- and glucuronyltransferase 1 0.526 0.654 0.99
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 7392
Gene Symbol: USF2
USF2 		upstream transcription factor 2, c-fos interacting 0.626 0.654 0.99
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 6103
Gene Symbol: RPGR
RPGR 		retinitis pigmentosa GTPase regulator 0.536 0.692 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2020 2020
Entrez Id: 4781
Gene Symbol: NFIB
NFIB 		nuclear factor I B 0.573 0.654 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 56894
Gene Symbol: AGPAT3
AGPAT3 		1-acylglycerol-3-phosphate O-acyltransferase 3 0.931 0.038 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 9863
Gene Symbol: MAGI2
MAGI2 		membrane associated guanylate kinase, WW and PDZ domain containing 2 0.579 0.654 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 10659
Gene Symbol: CELF2
CELF2 		CUGBP Elav-like family member 2 0.628 0.692 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 23245
Gene Symbol: ASTN2
ASTN2 		astrotactin 2 0.666 0.462 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019